Spravato 28 mg nasal spray (each device delivers two sprays containing a total of 28 mg of esketamine) Images

Generic Name: esketamine

This medication has been identified as Spravato 28 mg nasal spray (each device delivers two sprays containing a total of 28 mg of esketamine). It is supplied by Janssen Pharmaceuticals, Inc.

Spravato is used in the treatment of Major Depressive Disorder; Depression and belongs to the drug class miscellaneous antidepressants. Spravato 28 mg nasal spray (each device delivers two sprays containing a total of 28 mg of esketamine) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images of medication

Spravato

Generic Name

esketamine

Strength

28 mg nasal spray (each device delivers two sprays containing a total of 28 mg of esketamine)

Availability

Prescription only

Drug Class

Miscellaneous antidepressants

CSA Schedule

3 - Moderate abuse potential

Labeler / Supplier

Janssen Pharmaceuticals, Inc.

National Drug Code (NDC)

50458-0028

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer